{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:55:41Z","timestamp":1790517341031,"version":"4.1.0"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,6,26]],"date-time":"2006-06-26T00:00:00Z","timestamp":1151280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2006,7]]},"abstract":"<jats:sec><jats:title>Summary<\/jats:title><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Emerging medications for non\u2010ulcer\u2010dyspepsia, such as the serotonin\u2010receptor modulators, also affect bowel habits by altering colonic transit. If drugs that alter colonic function were to prove useful in non\u2010ulcer dyspepsia, knowledge of baseline bowel habit disturbances would be potentially critical.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To estimate the rate of non\u2010ulcer dyspepsia patients with clinically relevant constipation or diarrhoea potentially precluding use of motility agents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Consecutive patients with non\u2010ulcer dyspepsia (<jats:italic>n<\/jats:italic>\u2003=\u200379), gastro\u2010oesophageal reflux disease (<jats:italic>n<\/jats:italic>\u2003=\u2003135) and organic upper gastrointestinal disease (upper gastrointestinal disease; <jats:italic>n<\/jats:italic>\u2003=\u200336) completed a validated symptom questionnaire evaluating predominant bowel habits in the last year.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Prevalence of constipation was higher in non\u2010ulcer dyspepsia (34%) than in gastro\u2010oesophageal reflux disease (<jats:italic>P<\/jats:italic>\u2003=\u20030.01) and organic upper gastrointestinal disease (<jats:italic>P<\/jats:italic>\u2003=\u20030.01), prevalence of alternating diarrhoea\/constipation (24%) and diarrhoea (22%) was similar, while prevalence of normal bowel habits was significantly less in non\u2010ulcer dyspepsia (20%; <jats:italic>P<\/jats:italic>\u2003=\u20030.01 vs. gastro\u2010oesophageal reflux disease and <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01 vs. organic upper gastrointestinal disease). Constipation was particularly frequent in ulcer\u2010like and dysmotility\u2010like non\u2010ulcer dyspepsia, while prevalence of diarrhoea was lowest in dysmotility\u2010like non\u2010ulcer dyspepsia. A normal bowel habit was equally uncommon in male (21%) and female non\u2010ulcer dyspepsia patients (20%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Only one of five non\u2010ulcer dyspepsia patients had normal bowel habits based on clinical symptoms; constipation is particularly prevalent. Patients with functional dyspepsia who are prescribed motility altering drugs should be evaluated by taking a thorough bowel habit history.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2006.02992.x","type":"journal-article","created":{"date-parts":[[2006,6,26]],"date-time":"2006-06-26T15:49:50Z","timestamp":1151336990000},"page":"405-410","source":"Crossref","is-referenced-by-count":12,"title":["Disturbed bowel habits in patients with non\u2010ulcer dyspepsia"],"prefix":"10.1111","volume":"24","author":[{"given":"J.","family":"HAMMER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. J.","family":"TALLEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,6,26]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2008.ii37"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90764-P"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3528(98)90017-3"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90373-9"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07699.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050404"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02212678"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.05.030"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00786.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70251-4"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01103.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00941.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07418.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01775.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.021857"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-8-671"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2008.ii1"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00225.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609006404"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059030-00008"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2005.41.10.920427"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.1.100-a"},{"key":"e_1_2_6_24_2","first-page":"CD003960","article-title":"Tegaserod for the treatment of irritable bowel syndrome","volume":"1","author":"Evans BW","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90142-Y"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.37095"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296098"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2006.02992.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2006.02992.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T07:22:18Z","timestamp":1697181738000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2006.02992.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,26]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.1111\/j.1365-2036.2006.02992.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2006.02992.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,26]]}}}